XML 104 R4.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenues    
Total revenues $ 502,080 $ 326,694
Expenses    
Cost of sales 248,714 142,804
Operating expenses 32,438 25,317
General and administrative 3,116 3,683
Acquisition and transaction expenses 7,292 6,179
Management fees and incentive allocation to affiliate 0 4,895
Depreciation and amortization 59,562 49,920
Asset impairment 0 962
Total expenses 351,122 233,760
Other (expense) income    
Interest expense (62,040) (47,707)
Equity in losses of unconsolidated entities [1],[2] (7,614) (667)
Other income [3] 43,941 634
Total other expense (25,713) (47,740)
Income before income taxes 125,245 45,194
Provision for income taxes 22,859 5,572
Net income 102,386 39,622
Less: Dividends on preferred shares 6,115 8,335
Less: Loss on redemption of preferred shares 6,327 0
Net income attributable to shareholders $ 89,944 $ 31,287
Earnings per share:    
Basic (in dollars per share) $ 0.88 $ 0.31
Diluted (in dollars per share) $ 0.87 $ 0.31
Weighted average shares outstanding:    
Basic (in shares) 102,552,436 100,245,905
Diluted (in shares) 103,159,051 100,960,065
Aerospace products revenue    
Revenues    
Total revenues [4] $ 365,063 $ 189,057
Lease income    
Revenues    
Total revenues 68,471 53,240
Maintenance revenue    
Revenues    
Total revenues 49,607 45,790
Asset sales revenue    
Revenues    
Total revenues $ 18,939 $ 38,607
[1] Includes the profit elimination of $(6,950) and $0 for the three months ended March 31, 2025 and 2024, respectively, for sales to the 2025 Partnership within the Aerospace Products segment.
[2] Includes the profit elimination of $(6,950) and $0 for the three months ended March 31, 2025 and 2024, respectively, for sales to the 2025 Partnership.
[3] Includes gain on sale of $10,870 and $0 for the three months ended March 31, 2025 and 2024, respectively, for sales to the 2025 Partnership.
[4] Includes revenue of $100,638 and $0 for the three months ended March 31, 2025 and 2024, respectively, for sales to the 2025 Partnership. See Note 11 for additional information.